Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025)
Corcept Therapeutics (CORT) posted Change in Taxes of $1.0 million for Q4 2025, up 167.57% sequentially from -$1.5 million in Q3 2025, and down 15.6% YoY from $1.2 million in Q4 2024.
Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025) Analysis & Trends
Corcept Therapeutics has reported Change in Taxes for 5 years, with the latest figure at $1.0 million in Q4 2025.
- Quarterly Change in Taxes fell 15.6% year-over-year to $1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 million (down 71.09% YoY) and the FY2025 annual result came in at $1.1 million, down 71.09% from the prior year.
- Change in Taxes improved to $1.0 million in Q4 2025 per CORT's latest filing, from -$1.5 million in the prior quarter.
- Over five years, Change in Taxes peaked at $2.5 million in Q2 2022 and troughed at -$1.5 million in Q3 2025.
- A 5-year average of $738900.0 and a median of $579500.0 in 2021 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2022 and 2025: Change in Taxes jumped 56950.0% in 2022, then plunged 269.78% in 2025.
- Over 5 years, Change in Taxes stood at -$4000.0 in 2021, then surged by 56950.0% to $2.3 million in 2022, then tumbled by 107.17% to -$163000.0 in 2023, then jumped by 858.9% to $1.2 million in 2024, then decreased by 15.6% to $1.0 million in 2025.
- According to Business Quant data, Change in Taxes over the past three periods registered $1.0 million, -$1.5 million, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.04 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 910,000.00 |
| Sep 30, 2024 | 910,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 562,000.00 |
| Mar 31, 2024 | 562,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Dec 31, 2023 | -163,000.00 |
| Sep 30, 2023 | 518,000.00 |
| Sep 30, 2023 | 518,000.00 |